Literature DB >> 26998600

Schizophrenia genetics complements its mechanistic understanding.

Elizabeth K Ruzzo1, Daniel H Geschwind1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26998600      PMCID： PMC5310675          DOI： 10.1038/nn.4277

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  15 in total

1.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

Review 2.  Genetics and genomics of psychiatric disease.

Authors:  Daniel H Geschwind; Jonathan Flint
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

Review 3.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

Review 4.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

5.  Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

Authors:  Maria Suntsova; Elena V Gogvadze; Sergey Salozhin; Nurshat Gaifullin; Fedor Eroshkin; Sergey E Dmitriev; Natalia Martynova; Kirill Kulikov; Galina Malakhova; Gulnur Tukhbatova; Alexey P Bolshakov; Dmitry Ghilarov; Andrew Garazha; Alexander Aliper; Charles R Cantor; Yuri Solokhin; Sergey Roumiantsev; Pavel Balaban; Alex Zhavoronkov; Anton Buzdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

6.  CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Authors:  Damian M Kraus; Gary S Elliott; Hilary Chute; Thomas Horan; Karl H Pfenninger; Staci D Sanford; Stephen Foster; Sheila Scully; Andrew A Welcher; V Michael Holers
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 7.  Consensus paper: the role of the cerebellum in perceptual processes.

Authors:  Oliver Baumann; Ronald J Borra; James M Bower; Kathleen E Cullen; Christophe Habas; Richard B Ivry; Maria Leggio; Jason B Mattingley; Marco Molinari; Eric A Moulton; Michael G Paulin; Marina A Pavlova; Jeremy D Schmahmann; Arseny A Sokolov
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

8.  TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement.

Authors:  Allison R Bialas; Beth Stevens
Journal:  Nat Neurosci       Date:  2013-10-27       Impact factor: 24.884

9.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

10.  Schizophrenia risk from complex variation of complement component 4.

Authors:  Aswin Sekar; Allison R Bialas; Heather de Rivera; Avery Davis; Timothy R Hammond; Nolan Kamitaki; Katherine Tooley; Jessy Presumey; Matthew Baum; Vanessa Van Doren; Giulio Genovese; Samuel A Rose; Robert E Handsaker; Mark J Daly; Michael C Carroll; Beth Stevens; Steven A McCarroll
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962
View more
  6 in total

1.  Expression analysis and genotyping of DGKZ: a GWAS-derived risk gene for schizophrenia.

Authors:  Somayeh Alinaghi; Elham Alehabib; Amir Hossein Johari; Fatemeh Vafaei; Shima Salehi; Hossein Darvish; Hamid Ghaedi
Journal:  Mol Biol Rep       Date:  2019-05-13       Impact factor: 2.316

2.  Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patients.

Authors:  Shahrzad Rahimi; Arezou Sayad; Elham Moslemi; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2017-06-04       Impact factor: 3.584

3.  Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort.

Authors:  Jane A English; Lorna M Lopez; Aoife O'Gorman; Melanie Föcking; Magdalena Hryniewiecka; Caitriona Scaife; Sophie Sabherwal; Kieran Wynne; Patrick Dicker; Bart P F Rutten; Glynn Lewis; Stanley Zammit; Mary Cannon; Gerard Cagney; David R Cotter
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

4.  Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress.

Authors:  Melanie Föcking; Sophie Sabherwal; Hannah M Cates; Caitriona Scaife; Patrick Dicker; Magdalena Hryniewiecka; Kieran Wynne; Bart P F Rutten; Glyn Lewis; Mary Cannon; Eric J Nestler; Meike Heurich; Gerard Cagney; Stanley Zammit; David R Cotter
Journal:  Mol Psychiatry       Date:  2019-01-11       Impact factor: 15.992

5.  Diversity amongst human cortical pyramidal neurons revealed via their sag currents and frequency preferences.

Authors:  Shreejoy J Tripathy; Taufik A Valiante; Homeira Moradi Chameh; Scott Rich; Lihua Wang; Fu-Der Chen; Liang Zhang; Peter L Carlen
Journal:  Nat Commun       Date:  2021-05-03       Impact factor: 14.919

Review 6.  Emerging Roles of Complement in Psychiatric Disorders.

Authors:  Mélanie Druart; Corentin Le Magueresse
Journal:  Front Psychiatry       Date:  2019-08-21       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.